busulfan has been researched along with Anemia, Megaloblastic in 2 studies
Anemia, Megaloblastic: A disorder characterized by the presence of ANEMIA, abnormally large red blood cells (megalocytes or macrocytes), and MEGALOBLASTS.
Excerpt | Relevance | Reference |
---|---|---|
"The risk of major thrombosis is higher in ET patients aged more than 60 ys." | 2.39 | Treatment strategies in essential thrombocythemia. A critical appraisal of various experiences in different centers. ( Barbui, T; Brière, J; Dupuy, E; Finazzi, G; Kiladjian, JJ, 1996) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 1 (50.00) | 18.7374 |
1990's | 1 (50.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Larizza, P | 1 |
Barbui, T | 1 |
Finazzi, G | 1 |
Dupuy, E | 1 |
Kiladjian, JJ | 1 |
Brière, J | 1 |
1 review available for busulfan and Anemia, Megaloblastic
Article | Year |
---|---|
Treatment strategies in essential thrombocythemia. A critical appraisal of various experiences in different centers.
Topics: Adult; Aged; Alkylating Agents; Anemia, Megaloblastic; Arrhythmias, Cardiac; Bone Marrow Diseases; B | 1996 |
1 other study available for busulfan and Anemia, Megaloblastic
Article | Year |
---|---|
[Introduction and general data on the subject of the pathology of drugs].
Topics: Agranulocytosis; Anemia, Hemolytic; Anemia, Megaloblastic; Anemia, Sideroblastic; Bleomycin; Bone Ma | 1984 |